6 vs 3 cycles of chemo before surgery for ovarian cancer
Treatments studied
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial compares 6 cycles of total neoadjuvant chemotherapy to 3 cycles in people with advanced ovarian cancer who have a partial response or stable disease after initial chemo. The goal is to see if more chemo before surgery improves outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have recently been diagnosed with stage III or IV ovarian cancer.
- You are eligible for platinum-based chemotherapy.
- You had a partial response or stable disease after 3-4 cycles of neoadjuvant chemotherapy.
- You have not had ovarian cancer come back (relapsed).
- You are a candidate for interval debulking surgery (surgery after chemo).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests giving chemotherapy directly into the abdomen (intraperitoneal) after optimal surgery for advanced ovarian cancer. It aims to see if this approach is safe and effective for women who have already received 3-4 cycles of chemotherapy before surgery.
This trial tests a different way of giving chemotherapy to people with advanced ovarian cancer that didn't respond well to initial treatment. The goal is to see if changing the dose and schedule can improve outcomes.
This trial tests a new combination of two immunotherapy drugs plus standard chemotherapy before surgery for advanced ovarian cancer. The goal is to see if this treatment shrinks the cancer more and makes surgery more effective.
This Phase 2 trial compares two different treatment strategies as the first chemotherapy after surgery for advanced epithelial ovarian, peritoneal, or fallopian-tube cancer. It may help doctors find a more effective or better-tolerated approach for people in your situation.
This trial compares two chemotherapy drugs (paclitaxel alone vs. paclitaxel plus carboplatin) given before surgery for advanced ovarian cancer. It is specifically for people whose tumors have a high level of the PARK2 gene, which may make them respond better to one of the treatments.
This trial tests if laparoscopic surgery after 3-4 cycles of chemotherapy can help people with advanced epithelial ovarian cancer. It's for those whose tumors have shrunk enough after chemo and who are healthy enough for surgery.
Hear when a new Stage III and IV Ovarian Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.